Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia [9]

Leukemia

Volumn 21, Issue 3, 2007, Pages 571-574

  Tyybakinoja A ^a   Elonen, E ^b   Piippo, K ^a   Porkka, K ^c   Knuutila, S ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c BIOMEDICUM HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD135 ANTIGEN; DNA; MYC PROTEIN; ONCOPROTEIN; PROTEIN NPM1; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ALLOGENEIC STEM CELL TRANSPLANTATION; AMPLICON; BONE MARROW BIOPSY; CANCER SURVIVAL; CHROMOSOME 12P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; GENE EXPRESSION; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN TISSUE; INTERPHASE; KARYOTYPE; LETTER; LEUKEMIA CELL; LEUKEMOGENESIS; MALE; METAPHASE; MINIMAL RESIDUAL DISEASE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROGNOSIS; TREATMENT OUTCOME; X CHROMOSOME; Y CHROMOSOME;

EID: 33847195418     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404543     Document Type: Letter

References (8)

1. Mrozek K, Marcucci G, Paschka P, Whitman SP, Bloomfield CD. Clinical relevance of mutations and gene-expression changes in adult acute myeloid leukemia with normal cytogenetics: Are we ready for a prognostically prioritized molecular classification? Blood 2007; 109: 431-448.
2. Dalley CD, Neat MJ, Foot NJ, Burridge M, Byrne L, Amess JA et al. Comparative genomic hybridization and multiplex-fluorescence in situ hybridization: An appraisal in elderly patients with acute myelogenous leukemia. Hematol J 2002; 3: 290-298.
3. Frohling S, Skelin S, Liebisch C, Scholl C, Schlenk RF, Dohner H et al. Comparison of cytogenetic and molecular cytogenetic detection of chromosome abnormalities in 240 consecutive adult patients with acute myeloid leukemia. J Clin Oncol 2002; 20: 2480-2485.
4. Paulsson K, Heidenblad M, Strombeck B, Staaf J, Jonsson G, Borg A et al. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration. Leukemia 2006; 20: 840-846.
5. Rucker FG, Bullinger L, Schwaenen C, Lipka DB, Wessendorf S, Frohling S et al. Disclosure of candidate genes in acute myeloid leukemia with complex karyotypes using microarray-based molecular characterization. J Clin Oncol 2006; 24: 3887-3894.
6. Tyybakinoja A, Saarinen-Pihkala U, Elonen E, Knuutila S. Amplified, lost, and fused genes in 11q23-25 amplicon in acute myeloid leukemia, an array-CGH study. Genes Chromosomes Cancer 2006; 45: 257-264.
7. Sato Y, Suto Y, Pietenpol J, Golub TR, Gilliland DG, Davis EM et al. TEL and KIP1 define the smallest region of deletions on 12p13 in hematopoietic malignancies. Blood 1995; 86: 1525-1533.
8. Storlazzi CT, Fioretos T, Surace C, Lonoce A, Mastrorilli A, Strombeck B et al. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene. Hum Mol Genet 2006; 15: 933-942.